Nurix Therapeuticsinc Stock Story
| NRIX Stock | USD 13.75 0.38 2.69% |
Slightly above 67% of Nurix TherapeuticsInc's investor base is looking to short. The analysis of the overall investor sentiment regarding Nurix TherapeuticsInc suggests that many traders are alarmed. Nurix TherapeuticsInc's investor sentiment overview provides quick insight into current market opportunities from investing in Nurix TherapeuticsInc. The current market sentiment, together with Nurix TherapeuticsInc's historical and current headlines, can help investors time the market. In addition, many technical investors use Nurix TherapeuticsInc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Nurix TherapeuticsInc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Nurix daily returns and investor perception about the current price of Nurix TherapeuticsInc as well as its diversification or hedging effects on your existing portfolios.
Nurix |
Requested story not found. it has been either deleted or moved. View all stories for Nurix TherapeuticsInc.
Nurix TherapeuticsInc Latest Timeline
Nurix TherapeuticsInc is listed for 13.75. About 77.0% of the company shares are owned by institutional investors. The book value of Nurix TherapeuticsInc was now reported as 3.43. The company recorded a loss per share of 2.66. Nurix TherapeuticsInc had not issued any dividends in recent years.Check out Nurix TherapeuticsInc Hype Analysis, Nurix TherapeuticsInc Correlation and Nurix TherapeuticsInc Performance. For more information on how to buy Nurix Stock please use our How to Invest in Nurix TherapeuticsInc guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Complementary Tools for Nurix Stock analysis
When running Nurix TherapeuticsInc's price analysis, check to measure Nurix TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nurix TherapeuticsInc is operating at the current time. Most of Nurix TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Nurix TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nurix TherapeuticsInc's price. Additionally, you may evaluate how the addition of Nurix TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Nurix TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nurix TherapeuticsInc. If investors know Nurix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nurix TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.66) | Revenue Per Share 1.483 | Quarterly Revenue Growth 0.307 | Return On Assets (0.29) | Return On Equity (0.65) |
The market value of Nurix TherapeuticsInc is measured differently than its book value, which is the value of Nurix that is recorded on the company's balance sheet. Investors also form their own opinion of Nurix TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Nurix TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nurix TherapeuticsInc's market value can be influenced by many factors that don't directly affect Nurix TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nurix TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nurix TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nurix TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.